American Conference Institute’s Drug and Medical Device Litigation Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers from the leading pharmaceutical and medical device companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

ACI Drug and Med Advisory Board

Patricia A. Barbieri

SVP, General Counsel and Secretary
Daiichi Sankyo, Inc. (Parsippany, NY)

Mary-Alice Barrett

Associate General Counsel
Genentech (Little Falls, NJ)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 8:45 am

Debra L. Burns

Senior Counsel Litigation/Investigations
GE Healthcare

Christopher M. Guth

Senior Assistant General Counsel
Bayer (Pittsburgh, PA)

Donald LeGower

Assistant General Counsel - Litigation and Government Investigations
Bristol-Myers Squibb (Lawrenceville, NJ)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 8:45 am

Richard W. Silbert

V.P., Chief Legal Strategist
Purdue Pharma L.P. (Stamford, CT)

Brennan Torregrossa

Senior Vice President, Head of Global Litigation
GSK (Philadelphia, PA)